Clinical trial

Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With…

NCT00366444 · Xanodyne Pharmaceuticals, Industry · Completed

Key facts

NCT number NCT00366444
Title Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
Official title Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery
Lead sponsor Xanodyne Pharmaceuticals, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Pain, Postoperative
Intervention type Drug
Interventions diclofenac potassium (XP21L), Placebo
Enrollment 201
Start date Aug 1, 2006
Primary completion Oct 1, 2006
First posted Aug 21, 2006
Last update posted Apr 13, 2011
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies